Search

Search Constraints

You searched for: Author/Creator Li, Bob T.

Search Results

1. Afatinib in patients with metastatic or recurrent HER2-mutant lung cancers: a retrospective international multicentre study. (March 2019)

2. ALK‐Rearranged Non‐Small Cell Lung Cancer in 2020: Real‐World Triumphs in an Era of Multigeneration ALK‐Inhibitor Sequencing Informed by Drug Resistance Profiling. (2nd July 2020)

5. Characterization of Central Nervous System Clinico-Genomic Outcomes in ALK-Positive Non-Small Cell Lung Cancer Patients with Brain Metastases Treated with Alectinib. (April 2023)

6. Clinical implications of drug‐induced liver injury in early‐phase oncology clinical trials. Issue 22 (18th August 2020)

7. Clinical utility of next-generation sequencing-based ctDNA testing for common and novel ALK fusions. (September 2021)

8. Clinical validation of Guardant360 CDx as a blood-based companion diagnostic for sotorasib. (April 2022)

9. Correlating Ki67 and other prognostic markers with Oncotype DX recurrence score in early estrogen receptor‐positive breast cancer. Issue 2 (29th September 2017)

10. Corrigendum to "Clinical utility of next-generation sequencing-based ctDNA testing for common and novel ALK fusions" [Lung Cancer 159 (2021) 66–73]. (December 2021)